Your browser doesn't support javascript.
loading
Genetic modifiers of radon-induced lung cancer risk: a genome-wide interaction study in former uranium miners.
Rosenberger, Albert; Hung, Rayjean J; Christiani, David C; Caporaso, Neil E; Liu, Geoffrey; Bojesen, Stig E; Le Marchand, Loic; Haiman, Ch A; Albanes, Demetrios; Aldrich, Melinda C; Tardon, Adonina; Fernández-Tardón, G; Rennert, Gad; Field, John K; Kiemeney, B; Lazarus, Philip; Haugen, Aage; Zienolddiny, Shanbeh; Lam, Stephen; Schabath, Matthew B; Andrew, Angeline S; Brunnsstöm, Hans; Goodman, Gary E; Doherty, Jennifer A; Chen, Chu; Teare, M Dawn; Wichmann, H-Erich; Manz, Judith; Risch, Angela; Muley, Thomas R; Johansson, Mikael; Brennan, Paul; Landi, Maria Teresa; Amos, Christopher I; Pesch, Beate; Johnen, Georg; Brüning, Thomas; Bickeböller, Heike; Gomolka, Maria.
Affiliation
  • Rosenberger A; Department of Genetic Epidemiology, University Medical Center, Georg August University Göttingen, Humboldtallee 32, 37073, Göttingen, Germany. arosenb@gwdg.de.
  • Hung RJ; Lunenfeld-Tanenbaum Research Institute, Sinai Health System, University of Toronto, Toronto, ON, Canada.
  • Christiani DC; Department of Environmental Health, Harvard T.H. Chan School of Public Health and Massachusetts General Hospital/Harvard Medical School, Boston, MA, USA.
  • Caporaso NE; Division of Cancer Epidemiology and Genetics, National Cancer Institute, US National Institutes of Health, Bethesda, MD, USA.
  • Liu G; Lunenfeld-Tanenbaum Research Institute, Sinai Health System, University of Toronto, Toronto, ON, Canada.
  • Bojesen SE; Department of Clinical Biochemistry, Herlev and Gentofte Hospital, Copenhagen University Hospital, Copenhagen, Denmark.
  • Le Marchand L; Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark.
  • Haiman CA; Copenhagen General Population Study, Herlev and Gentofte Hospital, Copenhagen, Denmark.
  • Albanes D; Epidemiology Program, University of Hawaii Cancer Center, Honolulu, HI, USA.
  • Aldrich MC; Department of Preventive Medicine, Keck School of Medicine, University of Southern California Norris Comprehensive Cancer Center, Los Angeles, CA, USA.
  • Tardon A; Division of Cancer Epidemiology and Genetics, National Cancer Institute, US National Institutes of Health, Bethesda, MD, USA.
  • Fernández-Tardón G; Division of Epidemiology, Department of Thoracic Surgery, Vanderbilt University Medical Center, Nashville, TN, USA.
  • Rennert G; Faculty of Medicine, University of Oviedo and CIBERESP, Oviedo, Spain.
  • Field JK; Faculty of Medicine, University of Oviedo and CIBERESP, Oviedo, Spain.
  • Kiemeney B; Clalit National Cancer Control Center at Carmel Medical Center and Technion Faculty of Medicine, Haifa, Israel.
  • Lazarus P; Institute of Translational Medicine, University of Liverpool, Liverpool, UK.
  • Haugen A; Departments of Health Evidence and Urology, Radboud University Medical Center, Nijmegen, The Netherlands.
  • Zienolddiny S; Department of Pharmaceutical Sciences, College of Pharmacy, Washington State University, Spokane, WA, USA.
  • Lam S; National Institute of Occupational Health, Oslo, Norway.
  • Schabath MB; National Institute of Occupational Health, Oslo, Norway.
  • Andrew AS; British Columbia Cancer Agency, Vancouver, BC, Canada.
  • Brunnsstöm H; Department of Cancer Epidemiology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL, USA.
  • Goodman GE; Department of Epidemiology, Geisel School of Medicine, Hanover, NH, USA.
  • Doherty JA; Laboratory Medicine Region Skåne, Department of Clinical Sciences and Pathology, Lund University, Lund, Sweden.
  • Chen C; Swedish Medical Group, Seattle, WA, USA.
  • Teare MD; Department of Epidemiology, Geisel School of Medicine, Hanover, NH, USA.
  • Wichmann HE; Program in Epidemiology, Fred Hutchinson Cancer Research Center, Seattle, WA, USA.
  • Manz J; Department of Population Health Sciences, Huntsman Cancer Institute, University of Utah, Salt Lake City, UT, USA.
  • Risch A; Program in Epidemiology, Fred Hutchinson Cancer Research Center, Seattle, WA, USA.
  • Muley TR; School of Health and Related Research, University of Sheffield, Sheffield, UK.
  • Johansson M; Institute of Epidemiology II, Helmholtz Zentrum München-German Research Center for Environmental Health, Neuherberg, Germany.
  • Brennan P; Institute of Medical Informatics, Biometry and Epidemiology, Ludwig Maximilians University, Munich, Germany.
  • Landi MT; Institute of Medical Statistics and Epidemiology, Technical University of Munich, Munich, Germany.
  • Amos CI; Institute of Epidemiology II, Helmholtz Zentrum München-German Research Center for Environmental Health, Neuherberg, Germany.
  • Pesch B; Research Unit of Molecular Epidemiology, Helmholtz Zentrum München-German Research Center for Environmental Health, Neuherberg, Germany.
  • Johnen G; Thoraxklinik at University Hospital Heidelberg, Heidelberg, Germany.
  • Brüning T; Translational Lung Research Center Heidelberg (TLRC-H), Heidelberg, Germany.
  • Bickeböller H; University of Salzburg and Cancer Cluster Salzburg, Salzburg, Austria.
  • Gomolka M; Thoraxklinik at University Hospital Heidelberg, Heidelberg, Germany.
Int Arch Occup Environ Health ; 91(8): 937-950, 2018 Nov.
Article in En | MEDLINE | ID: mdl-29971594
ABSTRACT

PURPOSE:

Radon is a risk factor for lung cancer and uranium miners are more exposed than the general population. A genome-wide interaction analysis was carried out to identify genomic loci, genes or gene sets that modify the susceptibility to lung cancer given occupational exposure to the radioactive gas radon.

METHODS:

Samples from 28 studies provided by the International Lung Cancer Consortium were pooled with samples of former uranium miners collected by the German Federal Office of Radiation Protection. In total, 15,077 cases and 13,522 controls, all of European ancestries, comprising 463 uranium miners were compared. The DNA of all participants was genotyped with the OncoArray. We fitted single-marker and in multi-marker models and performed an exploratory gene-set analysis to detect cumulative enrichment of significance in sets of genes.

RESULTS:

We discovered a genome-wide significant interaction of the marker rs12440014 within the gene CHRNB4 (OR = 0.26, 95% CI 0.11-0.60, p = 0.0386 corrected for multiple testing). At least suggestive significant interaction of linkage disequilibrium blocks was observed at the chromosomal regions 18q21.23 (p = 1.2 × 10-6), 5q23.2 (p = 2.5 × 10-6), 1q21.3 (p = 3.2 × 10-6), 10p13 (p = 1.3 × 10-5) and 12p12.1 (p = 7.1 × 10-5). Genes belonging to the Gene Ontology term "DNA dealkylation involved in DNA repair" (GO0006307; p = 0.0139) or the gene family HGNC476 "microRNAs" (p = 0.0159) were enriched with LD-blockwise significance.

CONCLUSION:

The well-established association of the genomic region 15q25 to lung cancer might be influenced by exposure to radon among uranium miners. Furthermore, lung cancer susceptibility is related to the functional capability of DNA damage signaling via ubiquitination processes and repair of radiation-induced double-strand breaks by the single-strand annealing mechanism.
Subject(s)
Key words

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Carcinogens, Environmental / Radon / Receptors, Nicotinic / Lung Neoplasms / Neoplasms, Radiation-Induced / Nerve Tissue Proteins / Occupational Diseases Type of study: Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Female / Humans / Male / Middle aged Language: En Journal: Int Arch Occup Environ Health Year: 2018 Type: Article Affiliation country: Germany

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Carcinogens, Environmental / Radon / Receptors, Nicotinic / Lung Neoplasms / Neoplasms, Radiation-Induced / Nerve Tissue Proteins / Occupational Diseases Type of study: Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Female / Humans / Male / Middle aged Language: En Journal: Int Arch Occup Environ Health Year: 2018 Type: Article Affiliation country: Germany